Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen

Yong, KL, Brown, S, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (8 more authors) (2015) Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen. In: Blood. 57th ASH Annual Meeting and Exposition, 05-08 Dec 2015, Orlando, FL, USA. American Society of Hematology .

Metadata

Authors/Creators:
Dates:
  • Published: 3 December 2015
  • Published (online): 3 December 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Aug 2018 10:36
Last Modified: 08 Aug 2018 10:36
Published Version: http://www.bloodjournal.org/content/126/23/1840
Status: Published
Publisher: American Society of Hematology

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export